home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc.

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: OTC
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

FREMONT, CA - ( NewMediaWire ) - May 09, 2024 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that in its fi...
ABVC - PHG, IBRX and MESO are among premarket gainers

2024-04-29 08:36:50 ET More on premarket gainers & stock Diving Into Deciphera Pharmaceuticals Fulton Financial Corporation (FULT) Q1 2024 Earnings Call Transcript Fulton Financial Corporation 2024 Q1 - Results - Earnings Call Presentation Fulton Financia...

ABVC - BACK, ZPTA and ABVC are among premarket gainers

2024-04-24 09:12:50 ET More on premarket gainers and stock Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript B. Riley Financial: Audit Risk May Have Potential Rewards B...

ABVC - US Companies Moving the Markets, Evening edition
Tue, Apr 23, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Cyngn Inc. (CYN) fell 5.8% to $0.114 on volume of 321,909,962 shares Pineapple Energy Inc. (PEGY) rose 23.6% to $0.0566 on volume of 180,092,924 shares NewGenIvf Group Limited (NIVF) rose 74.2% to $2.23 on volume of 136,563,105 shares...
ABVC - AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced to...

ABVC - ABVC BioPharma executes licensing agreement with OncoX

2024-04-17 09:19:47 ET More on ABVC BioPharma ABVC Biopharma stock climbs on deal for its oncology/hematology products Financial information for ABVC BioPharma Read the full article on Seeking Alpha For further details see: ABVC BioPharma executes licensi...

ABVC - ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

FREMONT, CA  - ( NewMediaWire ) - April 17, 2024 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that the Comp...
ABVC - ABVC Biopharma stock climbs on deal for its oncology/hematology products

2024-04-10 09:23:05 ET More on ABVC BioPharma Financial information for ABVC BioPharma Read the full article on Seeking Alpha For further details see: ABVC Biopharma stock climbs on deal for its oncology/hematology products

ABVC - Notable Newsmakers

2024-04-10 09:19:47 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC ), Clearmind Medicine Inc. (NASDAQ: CMND ), Brera Holding (NASDAQ: BREA ), Goldman Sachs (NYSE: GS ), and JP Morgan (NYSE: JPM ). ABVC B...

ABVC - ABVC BioPharma Signs Global Licensing Term Sheet for Its Oncology/Hematology Products

2024-04-10 08:45:46 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC ) stated that it entered into a term sheet with OncoX BioPharma, Inc. for ABVC’s Oncology/Hematology pipeline and is set to receive $50,000,000 as licensing fees in th...
Next 10